Skip to content
Research Article Open access CC BY 4.0

The Relationship between Homocysteine ​​and Fragility Fractures - A Systematic Review

Alexandru Filip, Nina Filip, Bogdan Veliceasa, Cristiana Filip, Ovidiu Alexa

Annual Research & Review in Biology · pp. 1–8 · Published 9 Sep 2017

10.9734/ARRB/2017/36176

Abstract

It is known that increased levels of homocysteine in plasma ​​have been associated with various diseases. Current studies show that homocysteine ​​is a new risk factor for the development of osteoporosis. Fragility fractures are associated with increased morbidity, mortality and cause substantial financial loss to the patients and their families. This mini-review provides a critical overview of currently available studies, examining the relationship between plasma homocysteine levels and fragility fractures. In conclusion more studies are needed to establish a clear relationship between homocysteine and fractures in elderly patients.

Hyperhomocysteine osteoporosis fracture methionine bone fragility.

Cited by 4

Introductory Chapter: General Aspects Regarding Homocysteine

Nina Filip, C. Iancu · Non-Proteinogenic Amino Acids · 2018

Is Homocysteine a Marker or a Risk Factor: A Question Still Waits for an Answer

C. Filip, Elena Albu, Hurjui Ion · Non-Proteinogenic Amino Acids · 2018

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

4

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.